PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism

Cinacalcet lowers parathyroid hormone levels. Whether it can prolong survival of people with chronic kidney disease (CKD) complicated by secondary hyperparathyroidism (SHPT) remains controversial, in part because a recent randomized trial excluded patients with iPTH <300 pg/ml. We examined cinaca...

Full description

Bibliographic Details
Main Authors: Akizawa, Tadao, Kurita, Noriaki, Mizobuchi, Masahide, Fukagawa, Masafumi, Onishi, Yoshihiro, Yamaguchi, Takuhiro, Ellis, Alan R., Fukuma, Shingo, Alan Brookhart, M., Hasegawa, Takeshi, Kurokawa, Kiyoshi, Fukuhara, Shunichi
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829837/